Inventor

THORPE PHILIP E

US65 patents

⚠️ This page may combine multiple inventors who share the name “THORPE PHILIP E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THORPE PHILIP E

UNIV TEXAS

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

Antibody methods for selectively inhibiting VEGF

Antibody kits for selectively inhibiting VEGF

Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids

Antibody conjugate methods for selectively inhibiting VEGF

Antibody conjugate formulations for selectively inhibiting VEGF

Antibody methods for selectively inhibiting VEGF

Antibody conjugate kits for selectively inhibiting VEGF

Cancer treatment methods using antibodies to aminophospholipids

Antibody conjugate compositions for selectively inhibiting VEGF

Antibody compositions for selectively inhibiting VEGF

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

Diagnostic methods for targeting the vasculature of solid tumors

Methods and compositions for the specific coagulation of vasculature

Compositions for targeting the vasculature of solid tumors

Methods for targeting the vasculature of solid tumors

Methods for the specific coagulation of vasculature

Methods and compositions for targeting the vasculature of solid tumors

Compositions for targeting the vasculature of solid tumors

Methods for treating the vasculature of solid tumors

Methods for targeting the vasculature of solid tumors

Methods of using steroid-polyanionic polymer-based conjugated targeted to vascular endothelial cells

Antibodies that bind to endoglin

Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

Tissue factor methods and compositions for coagulation and tumor treatment

Combined methods and compositions for tumor vasculature targeting and tumor treatment

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

VEGF-gelonin for targeting the vasculature of solid tumors

Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

Combined methods for tumor coagulation and tumor treatment

Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

Combined cancer treatment methods using antibodies to aminophospholipids

Selected antibody CDRs for binding to aminophospholipids

Combined methods and compositions for coagulation and tumor treatment

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

Combined cancer treatment methods using selected antibodies to aminophospholipids

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

Methods and compositions for isolating exosomes

THORPE PHILIP E

Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids

Cancer treatment kits using antibodies to aminophospholipids

Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

Constructs binding to phosphatidylserine and their use in disease treatment

SCRIPPS RESEARCH INST

Kits and methods for the specific coagulation of vasculature

Tissue factor compositions and ligands for the specific coagulation of vasculature

ICRF PATENTS LIMITED

Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates

UT SW MEDICAL CTR AT DALLAS

Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells